Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
8.23
-0.15 (-1.79%)
At close: Apr 1, 2025, 4:00 PM
8.41
+0.18 (2.25%)
Pre-market: Apr 2, 2025, 4:14 AM EDT

Amneal Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Cash & Equivalents
110.5591.5425.98247.79341.38
Upgrade
Short-Term Investments
1.872.21.821.171.7
Upgrade
Cash & Short-Term Investments
112.4293.7427.8248.96343.07
Upgrade
Cash Growth
19.93%237.24%-88.83%-27.43%125.23%
Upgrade
Accounts Receivable
775.73613.73741.79662.58639
Upgrade
Other Receivables
32.8331.9354.6232.0629.22
Upgrade
Receivables
808.56645.66796.41694.64668.21
Upgrade
Inventory
612.45581.38530.74489.39490.65
Upgrade
Prepaid Expenses
46.549.5147.1345.0737.86
Upgrade
Restricted Cash
7.877.579.258.955.74
Upgrade
Other Current Assets
--0.533.16
Upgrade
Total Current Assets
1,5881,3781,4121,5201,552
Upgrade
Property, Plant & Equipment
523.69550.14589.36639604.71
Upgrade
Long-Term Investments
35.9237.0985.59--
Upgrade
Goodwill
597.44598.63598.85593.02522.81
Upgrade
Other Intangible Assets
732.38890.421,0961,1671,305
Upgrade
Long-Term Deferred Charges
2.824.432.211.62.65
Upgrade
Other Long-Term Assets
21.391415.4319.0119.7
Upgrade
Total Assets
3,5013,4733,7993,9404,006
Upgrade
Accounts Payable
259.84145.53166.84132.87154.14
Upgrade
Accrued Expenses
307.31246.01218.21220.57257.98
Upgrade
Short-Term Debt
10017960--
Upgrade
Current Portion of Long-Term Debt
224.2134.1329.9630.6145.23
Upgrade
Current Portion of Leases
16.0414.514.6815.4212.25
Upgrade
Current Income Taxes Payable
---2.525.54
Upgrade
Other Current Liabilities
222.36227.43263.11275.24201.77
Upgrade
Total Current Liabilities
1,130846.6752.8677.24676.9
Upgrade
Long-Term Debt
2,1622,4272,6322,7302,826
Upgrade
Long-Term Leases
91.0995.45108.81111.93115.74
Upgrade
Other Long-Term Liabilities
163.3341.7797.1237.0531.05
Upgrade
Total Liabilities
3,5463,4113,5903,5563,649
Upgrade
Common Stock
3.13.073.043.013
Upgrade
Additional Paid-In Capital
560.21539.24691.63658.35628.41
Upgrade
Retained Earnings
-607.06-490.18-406.18-276.2-286.82
Upgrade
Comprehensive Income & Other
-65.51-32.359.94-24.83-41.32
Upgrade
Total Common Equity
-109.2719.78298.42360.34303.27
Upgrade
Minority Interest
64.7341.52-89.4923.5453.47
Upgrade
Shareholders' Equity
-44.5461.3208.93383.88356.74
Upgrade
Total Liabilities & Equity
3,5013,4733,7993,9404,006
Upgrade
Total Debt
2,5932,7512,8452,8882,999
Upgrade
Net Cash (Debt)
-2,481-2,657-2,817-2,639-2,656
Upgrade
Net Cash Per Share
-8.03-15.08-18.66-17.38-17.83
Upgrade
Filing Date Shares Outstanding
309.97307.01151.5149.42147.7
Upgrade
Total Common Shares Outstanding
309.88306.57151.49149.41147.67
Upgrade
Working Capital
458.04531.27659.02842.87874.64
Upgrade
Book Value Per Share
-0.350.061.972.412.05
Upgrade
Tangible Book Value
-1,439-1,469-1,397-1,400-1,524
Upgrade
Tangible Book Value Per Share
-4.64-4.79-9.22-9.37-10.32
Upgrade
Land
8.119.0210.7111.544.94
Upgrade
Buildings
224.66227.84225.63230.99210.12
Upgrade
Machinery
546.56524.61485.44484.42414.68
Upgrade
Construction In Progress
78.267.6769.3458.2671.46
Upgrade
Leasehold Improvements
130.91126.46124.67123.51108.7
Upgrade
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q